pre-IPO PHARMA

metabomed PRESS RELEASE ARCHIVE

Sep 9, 2020

MetaboMed Appoints Ali Fattaey, Ph.D. as Chief Executive Officer English English


Dec 19, 2019

Metabomed Completes a $12.5 Million Raise in Order to Advance Its Lead Program Into Clinical Studies


Apr 5, 2016

Krebszellenstoffwechselunternehmen Metabomed schließt 18 Mio. US-Dollar schwere Serie-A-Finanzierungsrunde ab


Apr 4, 2016

Cancer Metabolism Company Metabomed Completes $18 Million Series A Financing


Google Analytics Alternative